News

“We are very pleased to add Eric’s scientific expertise and leadership to our already strong senior management team,” said Carl Hull, Gen-Probe’s president and chief operating officer. “We

For the fourth quarter of 2008, Illumina reported revenue of $160.9 million, up 43% over the $112.6 million reported in the fourth quarter of 2007 and up 7%

The capital infusion will also serve to further the development of other innovative magnetic resonance image analysis technologies designed to increase physician productivity and accuracy, improve patient outcomes,

The funds will enable DNA Therapeutics to advance the vectorization and the additional proofs of concept, and to achieve regulatory preclinical studies of its lead product, named Dbait.

Underwriters Laboratories certified the product on January 22, 2009 opening the way to customer deliveries of FreeHand throughout Europe and those other countries whose certification or licensing requirements

Novo Nordisk has previously reached a corporate decision to exit the oncology therapeutic area, resulting in the suspension of all ongoing oncology programs. Under the terms of the

This agreement resolves the parties’ dispute that was pending in the District Court of Texas. Acacia Research’s subsidiaries develop, acquire, and license patented technologies. They control over 100

Under the terms of the agreement, Millipore will pay $22.6 million, subject to closing adjustments, to acquire Guava. The transaction is expected to be slightly accretive to Millipore’s

As a result of their affiliation, American patients will receive access to specialized spine centers committed to transparency, quality, protocol-driven care and continuous quality improvement for the treatment